Health Care & Life Sciences » Pharmaceuticals | Hindustan Bio Sciences Ltd.

Hindustan Bio Sciences Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
1,681.80
1,981.70
251.20
369.60
180.00
1,834
Total Accounts Receivable
13,849.90
3,208.50
4,725.40
4,680.20
3,177.00
16,744
Inventories
2,038.70
903.20
11.00
-
792.00
1,138
Other Current Assets
-
-
11.70
-
129.00
320
Total Current Assets
17,570.50
6,093.30
4,999.20
5,049.80
4,278.00
20,036
Net Property, Plant & Equipment
20,796.10
20,022.90
706.80
631.00
584.00
591
Total Investments and Advances
468.20
225.30
-
-
-
-
Long-Term Note Receivable
2,800.00
3,451.80
2,200.00
2,205.10
-
-
Other Assets
51,244.90
50,307.40
50,488.10
50,467.30
31,947.00
35,389
Total Assets
93,383.10
80,532.40
58,777.00
58,694.40
37,110.00
56,293
ST Debt & Current Portion LT Debt
1,374.70
-
5,776.00
7,461.40
8,067.00
Accounts Payable
4,040.50
1,426.30
906.20
2,118.20
654.00
Income Tax Payable
311.90
85.40
-
74.50
-
Other Current Liabilities
403.30
286.70
255.40
260.40
211.00
Total Current Liabilities
6,130.40
1,798.40
6,937.60
9,914.60
8,932.00
Long-Term Debt
3,067.50
9,652.50
3,635.70
5,491.30
7,642.00
Deferred Taxes
503.30
431.60
382.90
341.10
301.00
Total Liabilities
9,197.90
11,450.90
10,573.30
15,405.90
16,574.00
Common Equity (Total)
84,185.20
69,081.60
48,203.70
43,288.50
20,536.00
Total Shareholders' Equity
84,185.20
69,081.60
48,203.70
43,288.50
20,536.00
Total Equity
84,185.20
69,081.60
48,203.70
43,288.50
20,536.00
Liabilities & Shareholders' Equity
93,383.10
80,532.40
58,777.00
58,694.40
37,110.00

About Hindustan Bio Sciences

View Profile
Address
H. No. 8-2-269/S, Road No. 2
Hyderabad TS 500034
India
Employees -
Website http://www.hindustanbiosciences.in
Updated 07/08/2019
Hindustan Bio Sciences Ltd. provides various services in the pharmaceutical and biotechnology sectors. Its product portfolio includes liquid injectables, liquid and dry syrups, eye, ear and nasal drops, pre-filled syringes and non sterile and sterile ointments, tablets and capsules. Its products include erythropoietin, APIs, drug intermediates and specialty fine chemicals.